Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

WENGER

Showing results (431-440 of 5,435) with videos related to

Pageof 544
Sort By:
Bulletin of the American College of Surgeons|September 2, 2009
Does the U.S. have the best health care system in the world?Ronald D Wenger
Journal of Cardiovascular Translational Research|June 19, 2010
Menopausal hormone therapy for cardiovascular protection--unfulfilled expectationsNanette K Wenger
Pharmacological Reviews|September 1, 1990
Pharmacology of cyclosporin (sandimmune). II. ChemistryR M Wenger
Chemical Society Reviews|April 23, 2011
Photoinduced electron and energy transfer in phenylene oligomersOliver S Wenger
Gender Medicine|June 7, 2011
Gender differences in cardiovascular risk: a varying variableNanette K Wenger
Neonatal Network : NN|March 1, 1993
Teaching families from diverse cultural backgroundsA F Wenger
Clinical Genetics|September 1, 1995
Sister chromatid exchange in Prader-Willi syndrome familiesS L Wenger
Cleveland Clinic Journal of Medicine|October 31, 1998
Addressing coronary heart disease risk in womenN K Wenger
The Journal of Bone and Joint Surgery. American Volume|April 11, 2012
Legg-Calvé-Perthes disease: Functional prognosis in an era of high expectations: commentary on an article by A. Noelle Larson, MD, et al.: "A prospective multicenter study of Legg-Calvé-Perthes disease. Functional and radiographic outcomes of nonoperative treatment at a mean follow-up of twenty years"Dennis R Wenger
Advances in Chronic Kidney Disease|August 28, 2013
Prevention of cardiovascular disease in women: highlights for the clinician of the 2011 American Heart Association GuidelinesNanette K Wenger
Pageof 544

Showing results (431-440 of 5,435) with videos related to

Sort By:
Pageof 544
Bulletin of the American College of Surgeons|September 2, 2009
Does the U.S. have the best health care system in the world?Ronald D Wenger
Journal of Cardiovascular Translational Research|June 19, 2010
Menopausal hormone therapy for cardiovascular protection--unfulfilled expectationsNanette K Wenger
Pharmacological Reviews|September 1, 1990
Pharmacology of cyclosporin (sandimmune). II. ChemistryR M Wenger
Chemical Society Reviews|April 23, 2011
Photoinduced electron and energy transfer in phenylene oligomersOliver S Wenger
Gender Medicine|June 7, 2011
Gender differences in cardiovascular risk: a varying variableNanette K Wenger
Neonatal Network : NN|March 1, 1993
Teaching families from diverse cultural backgroundsA F Wenger
Clinical Genetics|September 1, 1995
Sister chromatid exchange in Prader-Willi syndrome familiesS L Wenger
Cleveland Clinic Journal of Medicine|October 31, 1998
Addressing coronary heart disease risk in womenN K Wenger
The Journal of Bone and Joint Surgery. American Volume|April 11, 2012
Legg-Calvé-Perthes disease: Functional prognosis in an era of high expectations: commentary on an article by A. Noelle Larson, MD, et al.: "A prospective multicenter study of Legg-Calvé-Perthes disease. Functional and radiographic outcomes of nonoperative treatment at a mean follow-up of twenty years"Dennis R Wenger
Advances in Chronic Kidney Disease|August 28, 2013
Prevention of cardiovascular disease in women: highlights for the clinician of the 2011 American Heart Association GuidelinesNanette K Wenger
Pageof 544